Central retinal vein occlusion with secondary cilioretinal artery occlusion treated with intravitreal bevacizumab (Avastin)

Chung, Yu-Chien; Chen, Shih‐Jen; Lee, Shih-Yun; Lee, Fenq-Li; Lee, Sui-Mei

doi:10.1016/j.tjo.2012.08.007

Cited by 1 publication

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Only four other cases of combined CRVO and CLRAO treated with anti-VEGF have been reported. Two cases of combined CRVO and CLRAO had anatomical improvement after multiple monthly intravitreal injections of Avastin [ 17 ]. Another 2 cases with combined CRVO and CLRAO had functional and anatomical improvement after a single injection of Lucentis [ 18 ].…”

Section: Discussionmentioning

confidence: 99%

Clinical Features and Treatment Outcome of a Concurrent Central Retinal Vein Occlusion and Cilioretinal Artery Occlusion

Tesfaw¹,

Batra

Phan

2022

Case Rep Ophthalmol

View full text Add to dashboard Cite

We describe the clinical features and treatment outcome of a patient with combined central retinal vein occlusion and cilioretinal artery occlusion. A 52-year-old female presented to our clinic with decreased vision in the right eye for 4 days. Visual acuity and intraocular pressure were count fingers at 2&1/2M and 14 mm Hg in the right and 20/20 and 16 mm Hg in the left eye, respectively. Funduscopic exam and optical coherence tomography (OCT) of the right eye confirmed the diagnosis of concurrent cilioretinal artery occlusion and central retinal vein occlusion with segmental macular pallor in the territory of the cilioretinal artery, corresponding marked inner retina thickening on OCT and signs of vein occlusion. The patient received an intravitreal injection of bevacizumab and at 1-month follow-up, vision improved to 20/30 with corresponding anatomical improvement. It is very important to recognize combined central retinal vein occlusion and cilioretinal artery occlusion as they could be treated with intravitreal injections of anti-vascular endothelial growth factors with favorable treatment outcomes.

show abstract

Section: Discussionmentioning

confidence: 99%